Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1967 Apr;46(4):558–568. doi: 10.1172/JCI105557

Immunopathologic Studies of Systemic Lupus Erythematosus (SLE). I. Tissue-bound Immunoglobulins in Relation to Serum Antinuclear Immunoglobulins in Systemic Lupus and in Chronic Liver Disease with LE Cell Factor *

Kathryn H Svec 1,2,3, John D Blair 1,2,3, Melvin H Kaplan 1,2,3,†
PMCID: PMC442039  PMID: 4164259

Abstract

We studied the composition of tissue-bound immunoglobulins and of antinuclear factors by immunofluorescent techniques in five patients with systemic lupus and two with chronic liver disease associated with positive LE cell tests. Renal glomeruli in all seven demonstrated deposits of bound γG-globulin and complement, although the presence of γA- and γM-immunoglobulins was variable. Blood vessel walls contained primarily γG-globulin and complement in the systemic lupus patients, but such deposits were absent from vessels in the two with chronic liver disease.

We observed antinuclear factors, demonstrated by immunofluorescence, in all three immunoglobulin classes. In six of the seven patients, evidence was obtained of a correspondence between the classes of bound immunoglobulins in glomeruli and vessels and the serum titers of antinuclear immunoglobulins. These observations are consistent with the concept that immunoglobulin deposits in tissues may be derived at least in part from antinuclear factors.

Neither bound immunoglobulins nor complement was observed in liver parenchyma of the two patients with chronic liver disease or in two patients with systemic lupus and liver pathology. It thus seems doubtful that serum antibodies play a primary role in the pathogenesis of forms of chronic liver disease associated with positive LE cell tests.

Full text

PDF
559

Images in this article

561Image
on p.561
561Image
on p.561
562Image
on p.562
563Image
on p.563
565Image
on p.565

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARONSON A. R., MONTGOMERY M. M. Chronic liver disease with a "lupus erythematosus-like syndrome". Arch Intern Med. 1959 Oct;104:544–552. doi: 10.1001/archinte.1959.00270100030006. [DOI] [PubMed] [Google Scholar]
  2. BARNETT E. V., CONDEMI J. J., LEDDY J. P., VAUGHAN J. H. GAMMA-2, GAMMA-1A AND GAMMA-1M ANTINUCLEAR FACTORS IN HUMAN SERA. J Clin Invest. 1964 Jun;43:1104–1115. doi: 10.1172/JCI104995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BOZICEVICH J., NASOU J. P., KAYHOE D. E. Desoxyribonucleic acid (DNA)-bentonite flocculation test for lupus erythematosus. Proc Soc Exp Biol Med. 1960 Mar;103:636–640. doi: 10.3181/00379727-103-25620. [DOI] [PubMed] [Google Scholar]
  4. Barnett E. V., Vaughan J. H. Antinuclear antibodies in rabbit antisera. J Exp Med. 1966 Apr 1;123(4):733–746. doi: 10.1084/jem.123.4.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. CASALS S. P., FRIOU G. J., MYERS L. L. SIGNIFICANCE OF ANTIBODY TO DNA IN SYSTEMIC LUPUS ERYTHEMATOSUS. Arthritis Rheum. 1964 Aug;7:379–390. doi: 10.1002/art.1780070404. [DOI] [PubMed] [Google Scholar]
  6. CHRISTIAN C. L., HATFIELD W. B., CHASE P. H. Systemic lupus erythematosus. Cryoprecipitation of sera. J Clin Invest. 1963 Jun;42:823–829. doi: 10.1172/JCI104774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DIXON F. J., FELDMAN J. D., VAZQUEZ J. J. Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med. 1961 May 1;113:899–920. doi: 10.1084/jem.113.5.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. DIXON F. J., VAZQUEZ J. J., WEIGLE W. O., COCHRANE C. G. Pathogenesis of serum sickness. AMA Arch Pathol. 1958 Jan;65(1):18–28. [PubMed] [Google Scholar]
  9. FREEDMAN P., MARKOWITZ A. S. Gamma globulin and complement in the diseased kidney. J Clin Invest. 1962 Feb;41:328–334. doi: 10.1172/JCI104486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. FREEDMAN P., MARKOWITZ A. S. Isolation of antibody-like gamma-globulin from lupus glomeruli. Br Med J. 1962 Apr 28;1(5286):1175–1178. doi: 10.1136/bmj.1.5286.1175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. FREEDMAN P., PETERS J. H., KARK R. M. Localization of gamma-globulin in the diseased kidney. Arch Intern Med. 1960 Apr;105:524–535. doi: 10.1001/archinte.1960.00270160022005. [DOI] [PubMed] [Google Scholar]
  12. GAJDUSEK D. C. An autoimmune reaction against human tissue antigens in certain acute and chronic diseases. I. Serological investigations. AMA Arch Intern Med. 1958 Jan;101(1):9–29. doi: 10.1001/archinte.1958.00260130023003. [DOI] [PubMed] [Google Scholar]
  13. Krishnan C., Kaplan M. H. Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis. J Clin Invest. 1967 Apr;46(4):569–579. doi: 10.1172/JCI105558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. LACHMANN P. J., MULLER-EBERHARD H. J., KUNKEL H. G., PARONETTO F. The localization of in vivo bound complement in tissue section. J Exp Med. 1962 Jan 1;115:63–82. doi: 10.1084/jem.115.1.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. LANGE K., WASSERMAN E., SLOBODY L. B. The significance of serum complement levels for the diagnosis and prognosis of acute and subacute glomerulonephritis and lupus erythematosus disseminatus. Ann Intern Med. 1960 Oct;53:636–646. doi: 10.7326/0003-4819-53-4-636. [DOI] [PubMed] [Google Scholar]
  16. LEVY H. B., SOBER H. A. A simple chromatographic method for preparation of gamma globulin. Proc Soc Exp Biol Med. 1960 Jan;103:250–252. doi: 10.3181/00379727-103-25476. [DOI] [PubMed] [Google Scholar]
  17. MACKAY I. R., TAFT L. I. Renal biopsy, with particular reference to the study of diabetes mellitus, systemic lupus erythematosus and subacute glomerulonephritis. Australas Ann Med. 1961 Aug;10:178–191. doi: 10.1111/imj.1961.10.3.178. [DOI] [PubMed] [Google Scholar]
  18. MACLACHLAN M. J., RODNAN G. P., COOPER W. M., FENNELL R. H., Jr CHRONIC ACTIVE ("LUPOID") HEPATITIS; A CLINICAL, SEROLOGICAL, AND PATHOLOGICAL STUDY OF 20 PATIENTS. Ann Intern Med. 1965 Mar;62:425–462. doi: 10.7326/0003-4819-62-3-425. [DOI] [PubMed] [Google Scholar]
  19. MELLORS R. C., ORTEGA L. G., HOLMAN H. R. Role of gamma globulins in pathogenesis of renal lesions in systemic lupus erythematosus and chronic membranous glomerulonephritis, with an observation on the lupus erythematosus cell reaction. J Exp Med. 1957 Aug 1;106(2):191–202. doi: 10.1084/jem.106.2.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. MULLER-EBERHARD H. J., NILSSON U., ARONSSON T. Isolation and characterization of two beta1-glycoproteins of human serum. J Exp Med. 1960 Feb 1;111:201–215. doi: 10.1084/jem.111.2.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Marmont A. M. The transfusion of active LE plasma into nonlupus recipients, with a note on the LE-like cell. Ann N Y Acad Sci. 1965 Jun 30;124(2):838–851. doi: 10.1111/j.1749-6632.1965.tb19006.x. [DOI] [PubMed] [Google Scholar]
  22. OKUDA R., KAPLAN M. H., CUPPAGE F. E., HEYMANN W. DEPOSITION OF AUTOLOGOUS GAMMA GLOBULIN IN KIDNEYS OF RATS WITH NEPHROTIC RENAL DISEASE OF VARIOUS ETIOLOGIES. J Lab Clin Med. 1965 Aug;66:204–215. [PubMed] [Google Scholar]
  23. ORTEGA L. G., MELLORS R. C. Analytical pathology. IV. The role of localized antibodies in the pathogenesis of nephrotoxic nephritis in the rat. J Exp Med. 1956 Jul 1;104(1):151–157. doi: 10.1084/jem.104.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Paronetto F., Koffler D. Immunofluorescent localization of immunoglobulins, complement, and fibrinogen in human diseases. I. Systemic lupus erythematosus. J Clin Invest. 1965 Oct;44(10):1657–1664. doi: 10.1172/JCI105272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. READ A. E., SHERLOCK S., HARRISON C. V. ACTIVE 'JUVENILE' CIRRHOSIS CONSIDERED AS PART OF A SYSTEMIC DISEASE AND THE EFFECT OF CORTICOSTEROID THERAPY. Gut. 1963 Dec;4:378–393. doi: 10.1136/gut.4.4.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. REYNOLDS T. B., EDMONDSON H. A., PETERS R. L., REDEKER A. LUPOID HEPATITIS. Ann Intern Med. 1964 Oct;61:650–666. doi: 10.7326/0003-4819-61-4-650. [DOI] [PubMed] [Google Scholar]
  27. SELIGMANN M. DNA ANTIBODIES. Arthritis Rheum. 1963 Aug;6:SUPPL–557. doi: 10.1002/art.1780060427. [DOI] [PubMed] [Google Scholar]
  28. TAFT L. I., MACKAY I. R., LARKIN L. Hepatitis complicated by manifestations of lupus erythematosus. J Pathol Bacteriol. 1958 Apr;75(2):399–404. doi: 10.1002/path.1700750218. [DOI] [PubMed] [Google Scholar]
  29. TOWNES A. S., STEWART C. R., Jr, OSLER A. G. Immunologic studies of systemic lupus erythematosus. II. Variations of nucleoprotein-reactive gamma globulin and hemolytic serum complement levels with disease activity. Bull Johns Hopkins Hosp. 1963 Apr;112:202–219. [PubMed] [Google Scholar]
  30. VAUGHAN J. H., BAYLES T. B., FAVOUR C. B. The response of serum gamma globulin level and complement titer to adrenocorticotropic hormone therapy in lupus erythematosus disseminatus. J Lab Clin Med. 1951 May;37(5):698–702. [PubMed] [Google Scholar]
  31. VAZQUEZ J. J., DIXON F. J. Immunohistochemical study of lesions in rheumatic fever, systemic lupus ervthematosus, and rheumatoid arthritis. Lab Invest. 1957 May-Jun;6(3):205–217. [PubMed] [Google Scholar]
  32. WARD J. R., CLOUD R. S., TURNER L. M., Jr NON-CYTOTOXICITY OF "NUCLEAR ANTIBODIES" FROM LUPUS ERYTHEMATOSUS SERA IN TISSUE CULTURE. Ann Rheum Dis. 1964 Sep;23:381–388. doi: 10.1136/ard.23.5.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. ZINKHAM W. H., CONLEY C. L. Some factors influencing the formation of L.E. cells; a method for enhancing L.E. cell production. Bull Johns Hopkins Hosp. 1956 Feb;98(2):102–119. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES